Patient-derived organoids CRO | Drug discovery | Organoid development services - HUB Organoids (original) (raw)
A PATIENT IN THE LAB®
HUB Organoids predict patient response to treatment.
Our patented technology allows the development of patient-derived “mini-organs in a dish” from both healthy and diseased tissues to close the gap between the lab and the clinic.
Award-winning recognition in drug discovery
HUB Organoids receives 2024 Frost & Sullivan Technology Innovation Leadership Award
What we can do for you
Drug development
Reduce drug attrition and predict patient response with our preclinical services and clinical trials in a dish
Link
Custom solutions
Decipher the complexity of the human disease with our custom model and assay development services
Link
Licensing program
Bring HUB Organoid Technology and knowhow in-house
Link
Our therapeutic areas
Immuno-oncology
Genetic
diseases
Infectious diseases
We’re already making an impact
by bringing next-generation therapeutics to patients
Bring HUB Organoid Technology and knowhow in-house  |
Outsource your drug development program  |
|---|
Latest news
NEWS & PRESS RELEASE
HUB Organoids B.V. Awarded Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Transforming Drug Development with Highly Advanced Organoid Technology
NEWS
Tumors in Space Investigates Microgravity’s Impact on Cancer Using Patient-Derived HUB Organoids
BLOG